NL7001141A - - Google Patents

Info

Publication number
NL7001141A
NL7001141A NL7001141A NL7001141A NL7001141A NL 7001141 A NL7001141 A NL 7001141A NL 7001141 A NL7001141 A NL 7001141A NL 7001141 A NL7001141 A NL 7001141A NL 7001141 A NL7001141 A NL 7001141A
Authority
NL
Netherlands
Application number
NL7001141A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7001141A publication Critical patent/NL7001141A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7001141A 1969-03-05 1970-01-27 NL7001141A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80466369A 1969-03-05 1969-03-05

Publications (1)

Publication Number Publication Date
NL7001141A true NL7001141A (fr) 1970-09-08

Family

ID=25189519

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7001141A NL7001141A (fr) 1969-03-05 1970-01-27

Country Status (4)

Country Link
US (1) US3573306A (fr)
BE (1) BE746816A (fr)
IL (1) IL33940A0 (fr)
NL (1) NL7001141A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1715867A1 (fr) * 2004-02-12 2006-11-02 Merck & Co., Inc. Amides bipyridyles en tant que modulateurs du r cepteur-5 metabotropique du glutamate

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196292A (en) * 1977-06-29 1980-04-01 Merck & Co., Inc. 6-Substituted amiloride derivatives
FI820266L (fi) * 1981-02-02 1982-08-03 Ici Plc Alkanolaminderivater
US6858614B2 (en) * 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenolic guanidine sodium channel blockers
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6903105B2 (en) * 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
JP2007502827A (ja) * 2003-08-18 2007-02-15 パリオン・サイエンシィズ・インコーポレーテッド 脂肪族ピラジノイルグアニジンナトリウムチャネルブロッカー
US20090253714A1 (en) * 2003-08-20 2009-10-08 Johnson Michael R Methods of reducing risk of infection from pathogens
US7745442B2 (en) * 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
JP2008540372A (ja) * 2005-05-03 2008-11-20 バイエル・クロツプサイエンス・エス・アー 新規ヘテロシクリルエチルアミド誘導体
US20070021439A1 (en) * 2005-07-25 2007-01-25 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
CN101939054B (zh) * 2007-12-10 2014-10-29 诺华股份有限公司 有机化合物
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
JP6165733B2 (ja) 2011-09-16 2017-07-19 ノバルティス アーゲー N−置換ヘテロシクリルカルボキサミド類
KR20150095870A (ko) 2012-12-17 2015-08-21 패리온 사이언스 인코퍼레이티드 3,5-디아미노-6-클로로-n-(n-(4-페닐부틸)카르밤이미도일)피라진-2-카르복스아미드 화합물
CN105073717B (zh) 2012-12-17 2018-05-22 帕里昂科学公司 可用于治疗由黏膜水化不足造成的疾病的氯-吡嗪甲酰胺衍生物
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
UY36034A (es) 2014-03-18 2015-09-30 Astrazeneca Ab Derivados de 3,5-diamino-6-cloro-pirazina-2-carboxamida y sales farmaceuticamente aceptables de estos
AR126669A1 (es) * 2021-08-02 2023-11-01 Eurofarma Laboratorios S A COMPUESTOS N-ACILIDRAZÓNICOS INHIBIDORES DE Nav 1.7 Y/O Nav 1.8, SUS PROCESOS DE OBTENCIÓN, COMPOSICIONES, USOS, MÉTODOS DE TRATAMIENTO DE ESTOS Y KITS

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1715867A1 (fr) * 2004-02-12 2006-11-02 Merck & Co., Inc. Amides bipyridyles en tant que modulateurs du r cepteur-5 metabotropique du glutamate
EP1715867A4 (fr) * 2004-02-12 2009-04-15 Merck & Co Inc Amides bipyridyles en tant que modulateurs du r cepteur-5 metabotropique du glutamate

Also Published As

Publication number Publication date
BE746816A (fr) 1970-09-04
US3573306A (en) 1971-03-30
IL33940A0 (en) 1970-04-20

Similar Documents

Publication Publication Date Title
AU465452B2 (fr)
AU429630B2 (fr)
AU450150B2 (fr)
CS148144B2 (fr)
AU470301B1 (fr)
AU5113869A (fr)
AU442535B2 (fr)
AU442380B2 (fr)
AU442322B2 (fr)
AU414607B2 (fr)
AU442463B2 (fr)
AU470661B1 (fr)
AU442538B2 (fr)
AU442554B2 (fr)
AU442285B2 (fr)
AU442357B2 (fr)
AU438128B2 (fr)
AU428131B2 (fr)
AU5109569A (fr)
AU5077469A (fr)
CS148794B1 (fr)
AU4949169A (fr)
BE739576A (fr)
AU4815038A (fr)
AU481328A (fr)